Format

Send to

Choose Destination
J Affect Disord. 2015 Oct 1;185:188-94. doi: 10.1016/j.jad.2015.06.048. Epub 2015 Jul 11.

Enduring effects of Preventive Cognitive Therapy in adults remitted from recurrent depression: A 10 year follow-up of a randomized controlled trial.

Author information

1
Utrecht University, Department of Clinical and Health Psychology, Utrecht, The Netherlands; University of Groningen, Department of Clinical Psychology, Groningen, The Netherlands. Electronic address: C.L.H.Bockting@UU.nl.
2
Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
3
Leiden University, Institute of Psychology and Department of Psychiatry, Leiden, The Netherlands.
4
Department of Psychiatry, University of Pennsylvania, Philadelphia, USA.
5
Department of Psychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Centre, Nijmegen, The Netherlands.

Abstract

BACKGROUND:

Prevention of recurrence is a challenge in the management of major depressive disorder (MDD). The long-term effects of Preventive Cognitive Therapy (PCT) in preventing recurrence in MDD are not known.

METHODS:

A RCT comparing the addition of PCT to Treatment As Usual (TAU), versus TAU including patients with recurrent depression who were in remission at entry (N=172). PCT consisted of eight weekly group sessions. TAU involved standard treatment. Primary outcome is time to first recurrence of a depressive episode as assessed by blinded interviewers over 10 years based on DSM-IV-TR criteria.

RESULTS:

Also over 10 years, the protective effect of PCT was dependent on the number of previous episodes a patient experienced. The protective effect intensified with the number of previous depressive episodes (Cox regression; p=.004, Hazard ratio=.576, 95% CI=.396-.837) and is mainly established within the first half of the 10 year follow-up period. For patients with more than three previous episodes (52% of the sample), PCT significantly increased the median survival time (713.0 days) versus patients that received TAU (205.0 days). No enduring effects were found on secondary outcomes.

LIMITATIONS:

Dropout rates were relatively high for secondary outcomes, but relatively low for the primary outcome. Results were comparable after multiple imputation.

CONCLUSIONS:

PCT in remitted patients with multiple prior episodes has long-term preventive effects on time to recurrence. To reduce recurrence rates, booster sessions might be necessary. A personalized medicine approach might be necessary to reduce recurrence rates even further.

KEYWORDS:

Cognitive therapy; Continuation treatment; Depressive disorder; Long-term effects; Maintenance; Prevention; Randomized controlled trial; Relapse/recurrence

PMID:
26188380
DOI:
10.1016/j.jad.2015.06.048
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center